155 related articles for article (PubMed ID: 34350623)
1. Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients with hematological malignancies.
Deng RX; Wu YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
Am J Hematol; 2021 Nov; 96(11):1407-1419. PubMed ID: 34350623
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Wang M
Chin Med J (Engl); 2013 Mar; 126(6):1096-102. PubMed ID: 23506585
[TBL] [Abstract][Full Text] [Related]
3. Elafin as a Predictive Biomarker of Acute Skin Graft-
Solán L; Carbonell D; Muñiz P; Dorado N; Landete E; Chicano-Lavilla M; Anguita J; Gayoso J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
Front Immunol; 2021; 12():516078. PubMed ID: 33679728
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features of Chronic Graft-Versus-Host Disease Following Haploidentical Transplantation Combined with Infusion of a Cord Blood.
Tao T; Li Z; Chu XL; Zhu WJ; Xu Y; Wu DP; Ma X; Xue SL
Stem Cells Dev; 2019 Jun; 28(11):745-753. PubMed ID: 30977441
[TBL] [Abstract][Full Text] [Related]
5. Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation.
Yang X; Yang S; Sun A; Qiu H; Tang X; Han Y; Wu D
Clin Transplant; 2018 Apr; 32(4):e13220. PubMed ID: 29493007
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience.
Zhou L; Gao ZY; Lu DP
Ann Hematol; 2020 Jun; 99(6):1389-1400. PubMed ID: 32291495
[TBL] [Abstract][Full Text] [Related]
7. [Effect of CD8
Zhang AD; Wei XX; Guo JY; Jin XS; Zhang LL; Li F; Gu ZY; Bo J; Dou LP; Liu DH; Li M; Gao CJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):896-905. PubMed ID: 38926986
[TBL] [Abstract][Full Text] [Related]
8. Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating Factor.
Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1655-1662. PubMed ID: 32504861
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of the efficacies of ruxolitinib plus low-dose PTCY for acute GVHD prevention after haploidentical transplantation in malignant hematological diseases].
Li XP; Li Y; Liu L; Yuan ZT; Wang YC; Dong YC; Zhang DS; Feng J; Chen YN; Wang SB
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):128-133. PubMed ID: 38604788
[No Abstract] [Full Text] [Related]
10. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
11. Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.
Stocker N; Duléry R; Battipaglia G; Brissot E; Médiavilla C; Sestili S; Paviglianiti A; Ledraa T; Mohty R; Bazarbachi A; Belhocine R; Vekhoff A; Ruggeri A; Mohty M; Malard F
Eur J Haematol; 2019 Jul; 103(1):10-17. PubMed ID: 30958904
[TBL] [Abstract][Full Text] [Related]
12. [Clinical Significance of Serum Immunoglobulin Level after Peri- pheral Blood Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies].
Lin T; Fang S; Wang FY; Gu ZY; Gao XN; Li F; Li M; Huang WR; Liu DH; Gao CJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1774-1781. PubMed ID: 33067989
[TBL] [Abstract][Full Text] [Related]
13. Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation.
Cao XH; Fan ZY; Chang YJ; Xu LP; Zhang XH; Huang XJ; Zhao XY
J Transl Med; 2024 Mar; 22(1):244. PubMed ID: 38448996
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous graft-versus-host disease incidence is similar in haploidentical and matched unrelated hematopoietic transplant recipients: A retrospective cohort study.
Heberton MM; Tripathi S; Slade M; Trinkaus K; Romee R; Anadkat M
J Am Acad Dermatol; 2020 Dec; 83(6):1654-1658. PubMed ID: 31689447
[TBL] [Abstract][Full Text] [Related]
15. Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.
Delios AM; Rosenblum M; Jakubowski AA; DeAngelis LM
J Neurooncol; 2012 Nov; 110(2):251-6. PubMed ID: 22915190
[TBL] [Abstract][Full Text] [Related]
16. Haploidentical hematopoietic stem cell transplantation for pediatric patients with chronic active Epstein-Barr virus infection: a retrospective analysis of a single center.
Luo YH; Yang J; Wei A; Zhu GH; Wang B; Zhang R; Jia CG; Yan Y; Wang K; Li S; Zhou X; Qin MQ; Wang TY
World J Pediatr; 2021 Dec; 17(6):626-636. PubMed ID: 34739695
[TBL] [Abstract][Full Text] [Related]
17. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
Kołodziejczak M; Gil L; de la Camara R; Styczyński J;
Ann Hematol; 2021 Mar; 100(3):763-777. PubMed ID: 33491135
[TBL] [Abstract][Full Text] [Related]
18. The incidence, risk factors, and outcomes of acute graft-vs-host disease in pediatric T-cell-replete haploidentical hematopoietic stem cell transplantation.
Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y
Pediatr Transplant; 2020 Nov; 24(7):e13793. PubMed ID: 32741088
[TBL] [Abstract][Full Text] [Related]
19. Haploidentical transplantation in pediatric non-malignant diseases: A retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH).
Torres Canizales J; Ferreras C; Pascual A; Alonso L; Regueiro A; Plaza M; Pérez Hurtado JM; Benito A; Couselo JM; Fuster JL; Díaz-Almirón M; Bueno D; Mozo Y; Gómez López A; Vicario JL; Balas A; Sisinni L; Díaz de Heredia C; Pérez-Martínez A
Eur J Haematol; 2021 Feb; 106(2):196-204. PubMed ID: 33084101
[TBL] [Abstract][Full Text] [Related]
20. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
Geng C; Liu X; Chen M; Yang C; Han B
Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
